Transaction DateRecipientSharesTypePriceValue
15th September 2020Advisors Llc Orbimed292,607Grant/award etc.$0.00
15th September 2020Advisors Llc Orbimed902,885Grant/award etc.$0.00
15th September 2020Carl L Gordon902,885Grant/award etc.$0.00
15th September 2020Advisors Llc Orbimed4,822,960Grant/award etc.$0.00
15th September 2020Carl L Gordon4,822,960Grant/award etc.$0.00
15th September 2020Carl L Gordon292,607Grant/award etc.$0.00
18th August 2020Advisors Llc Orbimed43,543Open or private sale$108.54$4,726,157.22
17th August 2020Advisors Llc Orbimed94,900Open or private sale$107.49$10,200,801.00
14th August 2020Advisors Llc Orbimed20,257Open or private sale$109.03$2,208,620.71
13th August 2020Advisors Llc Orbimed29,251Open or private sale$109.93$3,215,562.43
Prevail Therapeutics
Prevail Therapeutics logo

Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY.

Ticker: PRVL
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1714798
Employees: 55
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals